Hergenrother, Paul
- University of Illinois at Urbana-Champaign (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #2,207
- Sustained Excellence
- R01 Holder
- Long-Funded
- Mentor
- Diverse Portfolio
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$2.7M
Full award amounts, FY2023
Award Records
4
Records listing this PI
Award-Linked Rank
#2,207
By linked amount among FY2023 PIs
Earliest Year Loaded
2006
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Hergenrother, Paul as a PI. Multi-PI records show the full award amount for context.
- 1R01AI176523-01R01Contact PIFabI Inhibitors as Potent, Gut Microbiome-Sparing Antibiotics$977.8Kaward amount
- 5T32GM136629-04T32Contact PITraining Program at the Chemistry Biology Interface$636.6Kaward amount
- 5R01CA258746-02R01Contact PIA Novel Therapeutic Strategy for Ovarian Cancer$587.2Kaward amount
- 1R35CA283859-01R35Contact PIDeveloping a Suite of Targeted Anticancer Drugs$515.2Kaward amount
Award organization
Organizations that administered FY2023 awards listing Hergenrother, Paul as a PI.
FY2023 award administered by University of Illinois at Urbana-Champaign (IL).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2006First NIH AwardUniversity of Illinois at Urbana-Champaign
- 2007$500K Cumulative Funding
- 2009$1M Cumulative Funding
- 2009Entered Top 50% NationallyRanked #9960
- 2010$2M Cumulative Funding
- 2012R01 Grant Holder
- 2014$5M Cumulative Funding
- 2017Entered Top 25% NationallyRanked #4508
- 2018$10M Cumulative Funding
- 2018Entered Top 10% NationallyRanked #1225
- 2020Entered Top 5% NationallyRanked #688
- 2023$25M Cumulative Funding